Rapport Therapeutics, Inc. (RAPP) shareholders
Close on Nov 17, 2026Market cap $1.14BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Third Rock Ventures GP V, L.P. Joint filing with Third Rock Ventures V, L.P. (19.50%), Trv Gp V, LLC (19.50%) | 7,135,233 | 19.50% | 13G (passive) | Dec 31, 2024 |
| Trv Gp V, LLC Joint filing with Third Rock Ventures V, L.P. (13.10%), Third Rock Ventures GP V, L.P. (13.10%) | 6,280,525 | 13.10% | 13G (passive) amendment | Jun 30, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (15.00%) | 5,486,468 | 15.00% | 13G (passive) amendment | Nov 12, 2024 |
| S) Kristina Burow Joint filing with S) ARCH Venture Fund XII, L.P. (10.20%), S) ARCH Venture Partners XII, L.P. (10.20%) and 4 more | 3,728,738 | 10.20% | 13G (passive) | Sep 30, 2024 |
| Bihua Chen Joint filing with Cormorant Asset Management, LP (6.19%) | 2,957,521 | 6.19% | 13G (passive) amendment | Mar 31, 2026 |
| Capital International Investors | 2,921,958 | 6.10% | 13G (passive) amendment | Jun 30, 2026 |
| Cormorant Asset Management, LP Joint filing with Bihua Chen (5.56%) | 2,657,521 | 5.56% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 2,397,549 | 5.03% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RAPP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 7,172,894 | 14.95% | $298.89M | +3,955 | 0.01% |
| Trv Gp V, LLC | 6,280,525 | 13.09% | $261.71M | −854,708 | 52.53% |
| ARCH Venture Management, LLC | 3,728,738 | 7.77% | $155.38M | – | 14.12% |
| Capital International Investors | 2,921,958 | 6.09% | $121.76M | −176,015 | 0.03% |
| Goldman Sachs Group Inc | 2,910,449 | 6.07% | $121.28M | −31,802 | 0.01% |
| BlackRock, Inc. | 2,699,786 | 5.63% | $112.50M | +193,831 | 0.00% |
| Cormorant Asset Management, LP | 2,657,521 | 5.54% | $110.74M | −300,000 | 5.67% |
| Sofinnova Investments, Inc. | 1,904,408 | 3.97% | $79.36M | – | 4.10% |
| Johnson & Johnson | 1,784,517 | 3.72% | $74.36M | – | 9.31% |
| Polar Capital Holdings Plc | 1,608,514 | 3.35% | $67.03M | −33,947 | 0.16% |
| Baker Bros. Advisors LP | 1,547,090 | 3.22% | $64.47M | – | 0.32% |
| Vanguard Capital Management LLC | 1,346,512 | 2.81% | $56.11M | +21,430 | 0.00% |
| Trv Gp Vi, LLC | 969,218 | 2.02% | $40.39M | – | 17.39% |
| State Street Corp | 818,712 | 1.71% | $34.12M | +59,160 | 0.00% |
| Geode Capital Management, LLC | 793,453 | 1.65% | $33.07M | +71,831 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 787,446 | 1.64% | $32.81M | −79,010 | 0.00% |
| Perceptive Advisors LLC | 773,342 | 1.61% | $32.23M | +99,419 | 0.48% |
| Vestal Point Capital, LP | 730,000 | 1.52% | $30.42M | −706,229 | 0.71% |
| Alliancebernstein L.P. | 693,384 | 1.45% | $21.70M | −34,459 | 0.01% |
| UBS Asset Management Americas Inc | 644,082 | 1.34% | $26.84M | −274,784 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 161 | 51M | 100.0% | 29 / 57 | 46 / 12 | 2M | 3M |
| Q1 2026 | 147 | 52M | 100.0% | 30 / 52 | 35 / 24 | 5M | 2M |
| Q4 2025 | 144 | 51M | 100.0% | 40 / 51 | 30 / 20 | 5M | 3M |
| Q3 2025 | 124 | 49M | 100.0% | 51 / 38 | 19 / 9 | 13M | 3M |
| Q2 2025 | 82 | 38M | 80.2% | 15 / 28 | 19 / 9 | 2M | 2M |
| Q1 2025 | 77 | 38M | 79.4% | 17 / 35 | 9 / 9 | 2M | 1M |
| Q4 2024 | 70 | 37M | 76.2% | 20 / 18 | 15 / 5 | 9M | 1M |
| Q3 2024 | 55 | 28M | 59.3% | 30 / 11 | 7 / 10 | 4M | 1M |
| Q2 2024 | 35 | 26M | 53.3% | 35 / 0 | 0 / 0 | 26M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
174 funds held RAPP in Q2 2026, 26% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of RAPP | Value | % of fund | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 3,113,161 | 6.49% | $129.73M | 0.14% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 2,251,968 | 4.69% | $88.95M | 0.09% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 986,730 | 2.06% | $41.12M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 798,325 | 1.66% | $33.27M | 0.04% | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 687,115 | 1.43% | $27.14M | 0.10% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 592,106 | 1.23% | $23.39M | 0.10% | May 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 571,905 | 1.19% | $23.83M | 0.20% | Jun 30, 2026 |
| Select Biotechnology Portfolio | 428,273 | 0.89% | $16.92M | 0.32% | May 31, 2026 |
| Fidelity Small Cap Index Fund | 335,415 | 0.70% | $13.75M | 0.04% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 328,598 | 0.68% | $13.69M | 0.01% | Jun 30, 2026 |
| AB Small Cap Growth Portfolio | 301,476 | 0.63% | $12.56M | 0.40% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 278,547 | 0.58% | $11.61M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 264,229 | 0.55% | $11.01M | 0.07% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 229,745 | 0.48% | $9.57M | 0.09% | Jun 30, 2026 |
| iShares Biotechnology ETF | 200,630 | 0.42% | $8.36M | 0.09% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Abraham Ceesay | Chief Executive Officer, Director | 552,493 | 1.15% | Oct 23, 2026 |
| Troy A. Ignelzi | Chief Financial Officer | 15,500 | 0.03% | Oct 21, 2026 |
| Cheryl Gault | Chief Operating Officer | 139,914 | 0.29% | Oct 1, 2026 |
| Krishnaswamy Yeleswaram | Chief Development Officer | 212,063 | 0.44% | Aug 26, 2026 |
| David Bredt | Chief Scientific Officer | 393,075 | 0.82% | Feb 19, 2026 |
| Jeffrey Sevigny | Chief Medical Officer | – | – | Feb 4, 2026 |
| Trv Gp V, Llc | Director, 10% owner | – | – | Nov 3, 2026 |
| Third Rock Ventures VI, L.P. | Director, 10% owner | 7,401,933 | 15.43% | Nov 3, 2026 |
| Third Rock Ventures GP VI, L.P. | Director, 10% owner | – | – | Nov 3, 2026 |
| Trv Gp Vi, Llc | Director, 10% owner | – | – | Nov 3, 2026 |
| Third Rock Ventures V, L.P. | Director, 10% owner | 8,678,314 | 18.09% | Nov 3, 2026 |
| Third Rock Ventures GP V, LP | Director, 10% owner | – | – | Nov 3, 2026 |
| James Healy | Director | 2,873,888 | 5.99% | Oct 30, 2026 |
| Ramiro Sanchez | Director | 3,600 | 0.01% | Oct 23, 2026 |
| Paul M. Silva | Director | 3,680 | 0.01% | Oct 22, 2026 |
| Steven M. Paul | Director | 555,022 | 1.16% | Oct 22, 2026 |
| Wendy B. Young | Director | 13,289 | 0.03% | Oct 22, 2026 |
| John Maraganore | Director | 9,411 | 0.02% | Oct 22, 2026 |
| Reid M. Huber | Director | 20,400 | 0.04% | Jun 10, 2026 |
| Robert J. Perez | Director | – | – | Jun 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. Director, 10% owner | Oct 30, 2026 | Award | +1,190,476 | $21.00 | $25.00M | 2,159,694 |
| Third Rock Ventures V, L.P. Director, 10% owner | Oct 30, 2026 | Award | +238,095 | $21.00 | $5.00M | 6,518,620 |
| James Healy Director | Oct 28, 2026 | Buy | +6,933 | $21.00 | $145.59K | 25,267 |
| James Healy Director | Oct 28, 2026 | Buy | +3,772 | $21.00 | $79.21K | 14,924 |
| James Healy Director | Oct 28, 2026 | Buy | +6,395 | $21.00 | $134.30K | 17,990 |
| James Healy Director | Oct 28, 2026 | Buy | +952,380 | $21.00 | $20.00M | 2,815,707 |
| Ramiro Sanchez Director | Oct 23, 2026 | Buy | +3,600 | $27.35 | $98.48K | 3,600 |
| Paul M. Silva Director | Oct 22, 2026 | Buy | +3,680 | $27.07 | $99.64K | 3,680 |
| Wendy B. Young Director | Oct 22, 2026 | Buy | +3,789 | $26.39 | $99.99K | 13,289 |
| John Maraganore Director | Oct 22, 2026 | Buy | +1,172 | $26.92 | $31.55K | 9,411 |
| John Maraganore Director | Oct 22, 2026 | Buy | +8,239 | $26.38 | $217.34K | 8,239 |
| Steven M. Paul Director | Oct 22, 2026 | Buy | +35,714 | $27.28 | $974.28K | 77,380 |
| Abraham Ceesay Chief Executive Officer, Director | Oct 21, 2026 | Sale(10b5-1 plan) | −2,210 | $29.16 | $64.45K | 450,035 |
| Troy A. Ignelzi Chief Financial Officer | Oct 21, 2026 | Buy | +5,500 | $26.10 | $143.55K | 15,500 |
| Abraham Ceesay Chief Executive Officer, Director | Oct 7, 2026 | Sale(10b5-1 plan) | −1,147 | $30.66 | $35.17K | 452,245 |
| Abraham Ceesay Chief Executive Officer, Director | Oct 6, 2026 | Sale(10b5-1 plan) | −3,375 | $32.03 | $108.11K | 453,392 |
| Cheryl Gault Chief Operating Officer | Sep 30, 2026 | Sale(10b5-1 plan) | −2,075 | $33.76 | $70.04K | 139,914 |
| Cheryl Gault Chief Operating Officer | Sep 30, 2026 | Sale(10b5-1 plan) | −7,925 | $33.04 | $261.81K | 141,989 |
| Abraham Ceesay Chief Executive Officer, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −215 | $39.86 | $8.57K | 456,810 |
| Abraham Ceesay Chief Executive Officer, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −1,952 | $39.05 | $76.23K | 457,025 |
| Abraham Ceesay Chief Executive Officer, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −43 | $41.05 | $1.77K | 456,767 |
| Abraham Ceesay Chief Executive Officer, Director | Sep 8, 2026 | Sale(10b5-1 plan) | −1,069 | $46.01 | $49.18K | 458,977 |
| Abraham Ceesay Chief Executive Officer, Director | Sep 8, 2026 | Sale(10b5-1 plan) | −7,141 | $45.56 | $325.34K | 460,046 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 25, 2026 | Sale(10b5-1 plan) | −18,921 | $49.57 | $937.91K | 467,187 |
| Krishnaswamy Yeleswaram Chief Development Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −20,799 | $50.31 | $1.05M | 212,063 |
| Krishnaswamy Yeleswaram Chief Development Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −16,201 | $51.06 | $827.22K | 195,862 |
| Krishnaswamy Yeleswaram Chief Development Officer | Aug 24, 2026 | Sale(10b5-1 plan) | −13,160 | $50.00 | $658.00K | 232,862 |
| Krishnaswamy Yeleswaram Chief Development Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −404 | $49.90 | $20.16K | 246,022 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 11, 2026 | Sale(10b5-1 plan) | −5,794 | $48.62 | $281.70K | 486,108 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 11, 2026 | Sale(10b5-1 plan) | −19,500 | $48.04 | $936.78K | 491,902 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 11, 2026 | Sale(10b5-1 plan) | −3,664 | $46.90 | $171.84K | 511,402 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −8,370 | $46.75 | $391.30K | 515,066 |
| Abraham Ceesay Chief Executive Officer, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −14,171 | $45.97 | $651.44K | 523,436 |
| Abraham Ceesay Chief Executive Officer, Director | Jul 27, 2026 | Sale(10b5-1 plan) | −7 | $42.74 | $299 | 537,607 |
| Abraham Ceesay Chief Executive Officer, Director | Jul 27, 2026 | Sale(10b5-1 plan) | −2,203 | $42.11 | $92.77K | 537,614 |
| Abraham Ceesay Chief Executive Officer, Director | Jul 14, 2026 | Sale(10b5-1 plan) | −5,481 | $39.72 | $217.71K | 542,546 |
| Abraham Ceesay Chief Executive Officer, Director | Jul 14, 2026 | Sale(10b5-1 plan) | −2,729 | $40.57 | $110.72K | 539,817 |
| Cheryl Gault Chief Operating Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −3,792 | $41.39 | $156.95K | 154,222 |
| Cheryl Gault Chief Operating Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −1,900 | $40.09 | $76.17K | 158,014 |
| Cheryl Gault Chief Operating Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −3,308 | $42.17 | $139.50K | 150,914 |
| Cheryl Gault Chief Operating Officer | Jun 30, 2026 | Sale(10b5-1 plan) | −1,000 | $43.15 | $43.15K | 149,914 |
| Abraham Ceesay Chief Executive Officer, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −7,344 | $39.77 | $292.07K | 548,903 |
| Abraham Ceesay Chief Executive Officer, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −876 | $40.34 | $35.34K | 548,027 |
| Third Rock Ventures V, L.P. 10% owner | May 26, 2026 | Sale(10b5-1 plan) | −18,572 | $40.05 | $743.81K | 6,280,525 |
| Third Rock Ventures V, L.P. 10% owner | May 11, 2026 | Sale(10b5-1 plan) | −133,618 | $40.24 | $5.38M | 6,299,097 |
| Third Rock Ventures VI, L.P. 10% owner | May 8, 2026 | Sale(10b5-1 plan) | −5,018 | $40.31 | $202.28K | 6,432,715 |
| Third Rock Ventures VI, L.P. 10% owner | May 7, 2026 | Sale(10b5-1 plan) | −271,495 | $40.12 | $10.89M | 6,437,733 |
| Third Rock Ventures VI, L.P. 10% owner | Apr 17, 2026 | Sale(10b5-1 plan) | −426,005 | $40.32 | $17.18M | 6,709,228 |
| Krishnaswamy Yeleswaram Chief Development Officer | Apr 17, 2026 | Sale(10b5-1 plan) | −20,225 | $39.99 | $808.80K | 246,426 |
| Krishnaswamy Yeleswaram Chief Development Officer | Apr 14, 2026 | Sale(10b5-1 plan) | −10,200 | $35.08 | $357.82K | 266,651 |
| Krishnaswamy Yeleswaram Chief Development Officer | Apr 13, 2026 | Sale(10b5-1 plan) | −9,165 | $34.97 | $320.50K | 276,851 |
| Krishnaswamy Yeleswaram Chief Development Officer | Apr 10, 2026 | Sale(10b5-1 plan) | −500 | $34.98 | $17.49K | 286,016 |
| Krishnaswamy Yeleswaram Chief Development Officer | Apr 8, 2026 | Sale(10b5-1 plan) | −360 | $34.90 | $12.56K | 286,516 |
| Cheryl Gault Chief Operating Officer | Mar 30, 2026 | Sale(10b5-1 plan) | −2,839 | $28.55 | $81.05K | 159,914 |
| Cheryl Gault Chief Operating Officer | Mar 30, 2026 | Sale(10b5-1 plan) | −7,161 | $28.04 | $200.79K | 162,753 |
| Krishnaswamy Yeleswaram Chief Development Officer | Mar 25, 2026 | Sale(10b5-1 plan) | −10,115 | $29.99 | $303.35K | 286,876 |
| Cheryl Gault Chief Operating Officer | Mar 5, 2026 | Sale | −2,014 | $28.93 | $58.27K | 169,914 |
| David Bredt Chief Scientific Officer | Feb 19, 2026 | Option exercise | +6,000 | $1.80 | $10.80K | 393,075 |
| Abraham Ceesay Chief Executive Officer, Director | Feb 18, 2026 | Sale(10b5-1 plan) | −2,281 | $29.80 | $67.97K | 556,247 |
| Abraham Ceesay Chief Executive Officer, Director | Feb 18, 2026 | Sale(10b5-1 plan) | −2,983 | $29.04 | $86.63K | 22,829 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rapport Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 894 shares on Sep 3, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Abraham Ceesay Officer | Oct 6, 2026 | 39,470 | $1.23M | Oct 6, 2026 | Acquired as compensation -- Performance Awards |
| Cheryl Gault Officer | Sep 30, 2026 | 10,000 | $330.20K | Sep 30, 2026 | Founders Shares |
| Krishnaswamy Yeleswaram Officer | Aug 25, 2026 | 37,000 | $1.83M | Aug 25, 2026 | Founders Shares |
| Krishnaswamy Yeleswaram Officer | Aug 24, 2026 | 11,472 | $553.41K | Aug 24, 2026 | Founders Shares |
| Krishnaswamy Yeleswaram Officer | Aug 19, 2026 | 2,092 | $102.53K | Aug 19, 2026 | Founders Shares |
| Cheryl Gault Officer | Jun 30, 2026 | 10,000 | $403.90K | Jun 30, 2026 | Founders Shares |
| Abraham Ceesay Officer | Jun 29, 2026 | 99,480 | $4.02M | Jun 29, 2026 | Acquired as compensation -- Performance Awards |
| Third Rock Ventures V, L.P. 10% Stockholder | May 27, 2026 | 18,572 | $742.88K | May 26, 2026 | Original Issuance |
| Third Rock Ventures V, L.P. 10% Stockholder | May 11, 2026 | 133,618 | $5.38M | May 11, 2026 | Original Issuance |
| Third Rock Ventures V, L.P. 10% Stockholder | May 8, 2026 | 5,018 | $202.25K | May 8, 2026 | Original Issuance |
| Third Rock Ventures V, L.P. 10% Stockholder | May 7, 2026 | 271,495 | $10.89M | May 7, 2026 | Original Issuance |
| Krishnaswamy Yeleswaram Officer | Apr 17, 2026 | 20,225 | $799.70K | Apr 17, 2026 | Founders Shares |
| Third Rock Ventures V, L.P. 10% Stockholder | Apr 17, 2026 | 426,005 | $17.18M | Apr 17, 2026 | Original Issuance |
| Krishnaswamy Yeleswaram Officer | Apr 13, 2026 | 19,365 | $661.70K | Apr 13, 2026 | Founders Shares |
| Krishnaswamy Yeleswaram Officer | Apr 10, 2026 | 500 | $17.11K | Apr 10, 2026 | Founders Shares |
See a number that looks wrong?